PCDHB Inhibitors
Chemical inhibitors of Protocadherin Beta (PCDHB) can influence the protein's function by modifying the cellular environment in which it operates. Palmitoleic acid, by incorporating into cell membranes, can alter membrane fluidity, which in turn can affect PCDHB's capacity to mediate cell-cell adhesion. Similarly, cholesterol's pivotal role in maintaining membrane structure means that its modulation can lead to changes in PCDHB function; an increase in membrane cholesterol can enhance PCDHB's adhesion properties, while a decrease can inhibit it. Methyl-β-cyclodextrin works by extracting cholesterol from cell membranes, hence disrupting lipid rafts and, in turn, the stability and localization of PCDHB. GW4869 targets sphingomyelinase, an enzyme involved in the metabolism of sphingomyelin, a lipid that impacts membrane composition and signaling pathways related to PCDHB. An alteration in sphingomyelin levels can change the membrane dynamics, influencing PCDHB's function.
Further impacting PCDHB are inhibitors that target enzymes and signaling pathways crucial for its regulation. Manumycin A, by inhibiting farnesyltransferase, can affect the prenylation and membrane association of proteins interacting with PCDHB, thus modulating its signal transduction capabilities. PP2, as an Src family kinase inhibitor, can alter the kinase activity that regulates adhesion molecule functions, including those of PCDHB. The PI3K inhibitor LY294002 and EGFR tyrosine kinase inhibitor PD168393 can disrupt downstream signaling pathways that control PCDHB-mediated cell-cell adhesion. Y-27632 and ML7, as inhibitors of ROCK and myosin light chain kinase, respectively, can affect the cytoskeletal dynamics that are integral to PCDHB's role in cell adhesion. Blebbistatin's inhibition of myosin II ATPase activity can change cell contractility and adhesion, affecting the mechanical forces upon which PCDHB's function relies. Lastly, Genistein, by inhibiting various tyrosine kinases, can influence the phosphorylation state of PCDHB, thereby modulating its activity in cell-cell adhesion. Each of these inhibitors, by acting on different aspects of cell biochemistry and signaling, can impact the functional role of PCDHB within cellular adhesion processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palmitoleic acid | 373-49-9 | sc-205424 sc-205424A sc-205424B sc-205424C sc-205424D | 100 mg 500 mg 1 g 5 g 10 g | $33.00 $135.00 $238.00 $1039.00 $1907.00 | 4 | |
Palmitoleic acid can incorporate into cell membranes, potentially altering membrane fluidity and affecting membrane protein function. By altering the lipid microenvironment of PCDHB, its function in cell-cell adhesion could be inhibited as membrane interactions are crucial for its activity. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $27.00 $2809.00 $129.00 $210.00 $583.00 $88.00 | 11 | |
Cholesterol is a key component of cell membranes and can modulate membrane fluidity and the function of membrane proteins. By influencing the lipid raft composition, cholesterol can inhibit PCDHB function by disrupting its proper localization and interaction within the cell membrane. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
Methyl-β-cyclodextrin extracts cholesterol from cell membranes, disrupting lipid rafts. This disruption can inhibit PCDHB by affecting its membrane localization and stability, which are necessary for its adhesive functions. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 is an inhibitor of sphingomyelinase, which can lead to changes in the lipid composition of the cell membrane and influence the function of membrane proteins. Inhibiting sphingomyelinase activity could inhibit PCDHB by affecting its environment and function in the cell membrane. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A is a farnesyltransferase inhibitor, which could inhibit the prenylation and subsequent membrane association of proteins that interact with PCDHB. This could inhibit signal transduction pathways involving PCDHB, affecting its function in cell signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Since Src kinase activity can regulate the function of adhesion molecules, inhibiting Src kinases could indirectly inhibit PCDHB by disrupting downstream signaling pathways that regulate its adhesion functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, and PI3K signaling can regulate cell adhesion dynamics. Inhibition of PI3K could inhibit PCDHB by disturbing the signaling pathways that control its function in cell-cell adhesion. | ||||||
PD 168393 | 194423-15-9 | sc-222138 | 1 mg | $162.00 | 4 | |
PD168393 is an irreversible inhibitor of EGFR tyrosine kinase. EGFR signaling can affect cell adhesion molecules, so inhibiting EGFR could indirectly inhibit PCDHB function in cell-cell adhesion. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, and ROCK signaling affects cell shape and motility, which are related to cell adhesion. Inhibiting ROCK may inhibit PCDHB by altering the cytoskeleton and adhesion dynamics. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML7 is an inhibitor of myosin light chain kinase, which affects cytoskeletal dynamics and cell adhesion. Inhibiting myosin light chain kinase could inhibit PCDHB by altering the actin cytoskeleton, which is linked to cellular adhesion processes. | ||||||